InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: jakedogman1 post# 280136

Friday, 12/02/2016 1:21:47 PM

Friday, December 02, 2016 1:21:47 PM

Post# of 345787
Nice another Peregrine event presentation

I wonder why all these organizations are bringing Peregrines PS Targeting MOA pipeline wonders into their organizations?? I mean all I hear is Peregrine has nadda but all I continue to see and realize that Peregrine keeps appearing here and there and everywhere

Tough to nail down when they skyrocket when they are everywhere and PS Targeting is sought after by all those that KNOW PS Targeting is required for the most optimal and effective immune response

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News